Marked decrease in serum squamous cell carcinoma antigen level after antitumor necrosis factor alpha therapy in six cases of severe psoriasis.

Iriki, Hisato; Tanese, Keiji; Furuichi, Yuki; Takeshita, Kei; Saito, Masataka

Iriki, Hisato; Tanese, Keiji; Furuichi, Yuki; Takeshita, Kei; Saito, Masataka.

Afiliação

Iriki H; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
Tanese K; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. tanese@2001.jukuin.keio.ac.jp.
Furuichi Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
Takeshita K; Department of Respiratory Medicine, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan.
Saito M; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Int J Dermatol ; 55(6): e364-6, 2016 Jun.

Article em En | MEDLINE | ID: mdl-26696364

Assuntos

Adalimumab/uso terapêutico; Antígenos de Neoplasias/sangue; Fármacos Dermatológicos/uso terapêutico; Infliximab/uso terapêutico; Psoríase/sangue; Psoríase/tratamento farmacológico; Serpinas/sangue; Adulto; Idoso; Biomarcadores/sangue; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Índice de Gravidade de Doença; Fator de Necrose Tumoral alfa/antagonistas & inibidores

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Serpinas / Fármacos Dermatológicos / Adalimumab / Infliximab / Antígenos de Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google